Article Sidebar

pdf
Date Published: 09/07/2024
Abstract Views: 65
Views pdf: 12
DOI: https://doi.org/10.55046/vjrnm.53.998.2023
Issue
No. 53 (2023)
Section
Scientific research
How to Cite
Vu, T. T. L., Le, H. T., Nguyen , T. H., Nguyen , V. H., & VU, T. H. (2023). Role of the ultrasound- guided core needle biopsy in the assessment of cervical lymphadenopathy. Vietnamese Journal of Radiology and Nuclear Medicine, 53, 60-66. https://doi.org/10.55046/vjrnm.53.998.2023

Role of the ultrasound- guided core needle biopsy in the assessment of cervical lymphadenopathy

Vu Thi Thu Lan1, Le Huy Thai1, Nguyen Thi Hang1, Nguyen Viet Ha1, THI HOA VU2,
1 Central Military Hospital 108
2 Bệnh viện Trung Ương Quân Đội 108

Main Article Content

Abstract

Objective: To evaluate the effectiveness and factors influencing of ultrasound-guided core needle biopsy (US-CNB).


Subjects and Methods: A cross-sectional descriptive study was conducted on 201 patients with suspected cervical lymphadenopathy in clinical practice, having a transverse diameter ≥ 5mm, who underwent US-CNB at the Diagnostic Ultrasound Department of 108 Military Central Hospital from January 2022 to September 2023.


Results: A total of 201 suspected cervical lymphadenopathys, metastatic lymph nodes were the majority at 105 cases (52.2%), lymphoma at 32 cases (15.9%), and benign lymph nodes at 64 cases (31.9%). Adequate diagnostic and histopathological subtyping specimens constituted the majority with 126 cases (62.6%), specimens requiring additional testing for diagnosis were 51 cases (25.4%), specimens deemed inadequate were 7 cases (3.5%), and equivocal specimens requiring surgical excision were 17 cases (8.5%). The sensitivity, specificity, and accuracy of cervical lymphadenopathy US-CNB were 93.4%, 100%, and 95.5%, respectively. Among 32 lymphomas, 21 cases were diagnosed through US-CNB, and the remaining 11 cases required surgery, resulting in an overall accuracy of 65.6% for diagnosing lymphoma. Inadequate lymphadenopathy specimens were more common in the lymphoma group compared to metastatic and benign lymph nodes, and this difference was statistically significant with p < 0.05. Differences in transverse diameter, necrotic features, and needle size between the two groups were not statistically significant. No complications were encountered post-US-CNB.


Conclusion: US-CNB is a safe and effective method for diagnosing cervical lymphadenopathy with high accuracy and minimal invasiveness

Keywords

Biopsy, Ultrasound, cervical lymphadenopathy

Article Details

References

1. Bain G, Bearcroft P, Berman L, Grant J. The use of ultrasound-guided cutting-needle biopsy in paediatric neck masses. European radiology. 2000;10:512-515.
2. Oh K, Woo J-S, Cho J-G, Baek S, Jung K-Y, Kwon SY. Efficacy of ultrasound-guided core needle gun biopsy in diagnosing cervical lymphadenopathy. European Annals of Otorhinolaryngology, Head and Neck Diseases. 2016;133(6):401-404.
3. Kline TS, Kannan V, Kline IK. Lymphadenopathy and aspiration biopsy cytology. Review of 376 superficial nodes. Cancer. 1984;54(6):1076-1081.
4. Steel BL, Schwartz MR, Ramzy I. Fine needle aspiration biopsy in the diagnosis of lymphadenopathy in 1,103 patients. Role, limitations and analysis of diagnostic pitfalls. Acta cytologica. 1995;39(1):76-81.
5. Nasuti J, Yu G, Boudousquie A, Gupta P. Diagnostic value of lymph node fine needle aspiration cytology: an institutional experience of 387 cases observed over a 5 year period. Cytopathology. 2000;11(1):18-31.
6. Vassallo P, Wernecke K, Roos N, Peters PE. Differentiation of benign from malignant superficial lymphadenopathy: the role of high-resolution US. Radiology. 1992;183(1):215-220.
7. Screaton NJ, Berman LH, Grant JW. Head and neck lymphadenopathy: evaluation with US-guided cutting-needle biopsy. Radiology. 2002;224(1):75-81.
8. Pfeiffer J, Kayser G, Technau Ihling K, Boedeker CC, Ridder GJ. Ultrasound guided core needle biopsy in the diagnosis of head and neck masses: Indications, technique, and results. Head & Neck: Journal for the Sciences and Specialties of the Head and Neck. 2007;29(11):1033-1040.
9. Han F, Xu M, Xie T, et al. Efficacy of ultrasound-guided core needle biopsy in cervical lymphadenopathy: A retrospective study of 6,695 cases. European Radiology. 2018;28:1809-1817.
10. Jennings P, Coral A, Donald J, Rode J, Lees W. Ultrasound-guided core biopsy. The Lancet. 1989;333(8651):1369-1371.
11. Demharter J, Müller P, Wagner T, Schlimok G, Haude K, Bohndorf K. Percutaneous core-needle biopsy of enlarged lymph nodes in the diagnosis and subclassification of malignant lymphomas. European radiology. 2001;11:276-283.
12. Burke C, Thomas R, Inglis C, et al. Ultrasound-guided core biopsy in the diagnosis of lymphoma of the head and neck. A 9 year experience. The British journal of radiology. 2011;84(1004):727-732.
13. Huang PC, Liu CY, Chuang WY, Shih LY, Wan YL. Ultrasound-guided core needle biopsy of cervical lymphadenopathy in patients with lymphoma: the clinical efficacy and factors associated with unsuccessful diagnosis. Ultrasound in medicine & biology. 2010;36(9):1431-1436.
14. de Larrinoa AF, del Cura J, Zabala R, Fuertes E, Bilbao F, Lopez JI. Value of ultrasound guided core biopsy in the diagnosis of malignant lymphoma. Journal of Clinical Ultrasound. 2007;35(6):295-301.